ecteinascidin 743 has been researched along with Uveal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alsafadi, S; Decaudin, D; Etienne, V; Gelmi, MC; Glinkina, K; Jager, MJ; Jochemsen, AG; Kuipers, MJ; Nemati, F; Teunisse, AFAS | 1 |
1 other study(ies) available for ecteinascidin 743 and Uveal Neoplasms
| Article | Year |
|---|---|
Preclinical Evaluation of Trabectedin in Combination With Targeted Inhibitors for Treatment of Metastatic Uveal Melanoma.
Topics: Animals; c-Mer Tyrosine Kinase; Caspase 3; Cell Line, Tumor; Humans; Mice; Trabectedin; Uveal Neoplasms | 2022 |